came across this slide on Vitiligo R&D landscape... there's a lot happening in JAK inhibitor space - all of that leading to an increase in Serviceable Market for RECELL
Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt, page-118
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.82 |
Change
0.135(5.04%) |
Mkt cap ! $196.0M | |||
| Open | High | Low | Value | Volume |
| $2.78 | $2.86 | $2.77 | $207.6K | 74.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2804 | $2.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.82 | 4823 | 4 |
View Market Depth
| Last trade - 11.55am 16/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |